Shitova Maria, Alpeeva Elena, Vorotelyak Ekaterina
Laboratory of Cell Biology, N.K. Koltzov Institute of Developmental Biology of Russian Academy of Sciences, Vavilov Street 26, 119334 Moscow, Russia.
Int J Mol Sci. 2024 Dec 4;25(23):13054. doi: 10.3390/ijms252313054.
Cell immortalization has an important role in scientific research, as well as increasing significance in the context of cell therapy and biotechnology. Over the years, many immortalized cell lines have been produced using human telomerase reverse transcriptase (hTERT) alone or in a combination with viral oncogenes. Different hTERT-immortalized cells are commercially available, and numerous papers about obtaining immortalized cell lines have also been published. However, no specific list of characteristics that need to be checked to confirm successful immortalization exists. Most researchers evaluate only a few parameters, while different articles contain various opinions on the assessment of these characteristics. Results also vary significantly between different cell types, which have their own traits depending on their origin and functions. In the current paper, we raise these questions and discuss controversial issues concerning currently available testing methods for immortalization evaluation and the value and the limitations of the approaches. In addition, we propose a protocol for evaluation of hTERT immortalization success consisting of the following important steps: the assessment of the proliferation rate and dividing capacity, cell morphology, phenotype, karyotype stability, telomerase activity, the expression of cell-specific markers, and tumorigenicity. To our opinion, the hTERT expression level, telomere length, and senescence-associated β-galactosidase staining are controversial with regard to the implemented methods, so these parameters may be optional. For all the evaluation steps, we recommend to pay attention to the necessity of comparing the traits of the obtained immortalized and parent cells.
细胞永生化在科学研究中具有重要作用,在细胞治疗和生物技术领域的重要性也日益增加。多年来,人们使用人端粒酶逆转录酶(hTERT)单独或与病毒癌基因联合产生了许多永生化细胞系。不同的hTERT永生化细胞有商业供应,并且也发表了大量关于获得永生化细胞系的论文。然而,目前尚无用于确认成功永生化所需检查的特定特征清单。大多数研究人员仅评估少数几个参数,而不同的文章对这些特征的评估有各种观点。不同细胞类型之间的结果也有很大差异,这些细胞类型因其起源和功能而具有各自的特性。在本文中,我们提出这些问题,并讨论有关当前用于永生化评估的测试方法以及这些方法的价值和局限性的争议性问题。此外,我们提出了一种评估hTERT永生化成功与否的方案,该方案包括以下重要步骤:评估增殖率和分裂能力、细胞形态、表型、核型稳定性、端粒酶活性、细胞特异性标志物的表达以及致瘤性。我们认为,就所采用的方法而言,hTERT表达水平、端粒长度和衰老相关β-半乳糖苷酶染色存在争议,因此这些参数可能是可选的。对于所有评估步骤,我们建议注意比较获得的永生化细胞和亲本细胞特征的必要性。